Abstract:Autism spectrum disorder (ASD) is a complex developmental disorder with strong genetic components involved. Recent studies have demonstrated the importance of non‐coding regulatory variants for complex diseases. To explore the roles of chromosomal enhancer regions in the pathogenesis of ASD, we conducted an integrative analysis of genome‐wide association study (GWAS) and brain region related enhancer‐gene networks for ASD. The GWAS data of ASD were driven from a published study, involving 7,387 ASD cases and 8,567 controls. The enhancer‐gene networks of eight brain regions were used here. The GWAS of ASD was first merged respectively with the enhancer datasets of eight brain regions. Pathway enrichment analysis was then performed to detect ASD associated pathways based on the enhancer‐related single nucleotide polymorphism (SNPs) of each brain region. We detected multiple genes with brain region specific or common association signals, such as PGM3 ( P value = 1.93 × 10 −5 ) and RWDD2A ( P value = 1.93 × 10 −5 ) for hippocampus middle, and ENPP4 (all P values <0.05), and ENPP5 (all P values <0.05) for seven brain regions. By comparing the pathway enrichment analysis results of various brain regions, several cross brain regions pathways were detected for ASD, such as REACTOME_POTASSIUM_CHANNELS (all P values <0.05) for six brain regions and KEGG_CELL_ADHESION_MOLECULES_CAMS (all P values <0.05) for seven brain regions. In addition, several pathways were also identified for specific brain regions, such as REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING ( P value = 4.00 × 10 −3 ) for angular gyrus, REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR ( P value = 2.22 × 10 −3 ) for anterior caudate, and KEGG_PRION_DISEASES ( P value = 1.00 × 10 −4 ) for germinal matrix. Our results provide novel clues for understanding the genetic basis of ASD. Autism Research 2019, 12: 26–32 . © 2018 International Society for Autism Research, Wiley Periodicals, Inc. Lay Summary ASD is a complex developmental disorder with strong genetic components, but the pathogenesis of ASD is still unclear. Using the latest GWAS data and enhancer map, we explored the brain region related biological pathways associated with ASD. Our results provide novel clues for revealing the functional relevance of enhancer variants with ASD and understanding the genetic basis of ASD.

Unveiling promising drug targets for autism spectrum disorder: insights from genetics, transcriptomics, and proteomics

Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders

Integrated Transcriptome Analyses Revealed Key Target Genes in Mouse Models of Autism

Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing

A foundational atlas of autism protein interactions reveals molecular convergence

Drug repositioning based on network-specific core genes identifies potential drugs for the treatment of autism spectrum disorder in children

eQTL colocalization analysis highlights novel susceptibility genes in Autism Spectrum Disorders (ASD)

Targeted Resequencing of 358 Candidate Genes for Autism Spectrum Disorder in a Chinese Cohort Reveals Diagnostic Potential and Genotype-Phenotype Correlations

Mendelian Randomization Analysis of the Brain, Cerebrospinal Fl Uid, and Plasma Proteome Identi Fi Es Potential Drug Targets for Attention De Fi Cit Hyperactivity Disorder

Progress towards understanding risk factor mechanisms in the development of autism spectrum disorders

A scalable, high-throughput neural development platform identifies shared impact of ASD genes on cell fate and differentiation

Towards the convergent therapeutic potential of GPCRs in autism spectrum disorders

Genome-Wide Mendelian Randomization Reveals Genetically-Supported Drug Targets for Psychiatric Disorders

variants cause autism spectrum disorder the downregulation of WNT/β-catenin signaling pathway

Discovery and Validation of Novel Genes in a Large Chinese Autism Spectrum Disorder Cohort.

Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions

Identification of De Novo Mutations in the Chinese Autism Spectrum Disorder Cohort Via Whole-Exome Sequencing Unveils Brain Regions Implicated in Autism

Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders.

Proximity analysis of native proteomes reveals phenotypic modifiers in a mouse model of autism and related neurodevelopmental conditions

Genome‐wide Association Study and Identification of Chromosomal Enhancer Maps in Multiple Brain Regions Related to Autism Spectrum Disorder

Identification and Functional Analysis of Long Non-coding RNAs in Autism Spectrum Disorders